Vertex and Alexion Are Schooling Big Biotech

(Bloomberg Opinion) -- It’s been a pretty miserable year for biotech’s biggest names, rife with disappointments and sluggish share-price performance. Not so for two middlewights of the industry: Ve...

Bloomberg Quint

Add BloombergQuint App to Home screen.